Ireland's low taxes and generosity with incentives have been a big draw to makers of drugs for humans which have built and bought plants there. But veterinary biologics developer Nexvet Biopharma ($NVET) says it has been enticed as well. With help from the IDA, Nextvet subsidiary BioNua will establish a biologics plant in Tullamore and create up to 30 new jobs. It is paying €1.75 million ($1.98 million) to secure the manufacturing assets in a facility once used by Reliance GeneMedix. It will lease the facility for 10 years. Release